Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Biorestorative Therapies, Inc. (BRTX) had Stock-Based Compensation of $3.33M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.36M |
|
$-14.24M |
|
$0.02M |
|
$0.34M |
|
$16.01M |
|
$-15.65M |
|
$1.41M |
|
$-14.24M |
|
$-14.24M |
|
$-14.24M |
|
$-14.24M |
|
$-14.24M |
|
$-14.24M |
|
$-15.65M |
|
$-15.44M |
|
8.99M |
|
8.99M |
|
$-1.58 |
|
$-1.58 |
|
| Balance Sheet Financials | |
$3.14M |
|
$0.36M |
|
$0.94M |
|
$4.08M |
|
$3.72M |
|
-- |
|
-- |
|
$3.72M |
|
$0.34M |
|
$-0.18M |
|
$0.36M |
|
8.88M |
|
| Cash Flow Statement Financials | |
$-10.79M |
|
$8.90M |
|
$2.85M |
|
$0.55M |
|
$1.51M |
|
$0.96M |
|
|
Stock-Based Compensation |
$3.33M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
93.37% |
|
-4350.05% |
|
-4350.05% |
|
-4291.67% |
|
-3959.40% |
|
-3959.40% |
|
$-10.90M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
23.21 |
|
15.73 |
|
-4155.11% |
|
8025.73% |
|
-349.10% |
|
-3992.21% |
|
$0.04 |
|
$-1.21 |
|
$-1.20 |
|